News for Lattice Biologics Ltd. (LBLTF)

New York, USA, July 20, 2023 (GLOBE NEWSWIRE) -- Spine Biologics Market Overview According to a Comprehensive Research Report by Market Research Future...

Rising Sports-related Injuries and Increasing Cases of Oral Disorders Pushing Sales of Soft Tissue Allografts...

/PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Tissue Engineering-based Regeneration Products...

The US accounts for the highest number of tissue engineered skin substitutes pipeline products...

The Global Remote Patient Monitoring Market was worth USD 1.3 billion in 2020 and, with a CAGR of 12.1%, is expected to reach a market value of USD 4.07...

In 2020, the market was worth USD 6.15 billion and, with a CAGR of 5.71%, is expected to reach a market value of USD 10.71 billion by 2030 according to...

ISLAND PARK, Id. — Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) announces financial results for Q2 2021.

VANCOUVER, BC, June 7, 2021 /CNW/ - TSX VENTURE COMPANIESBULLETIN TYPE:  Cease Trade OrderBULLETIN DATE:  June 7, 2021TSX Venture CompanyCease Tra...

Lattice Biologics Ltd. ( TSX-V: LBL) (OTCBB: LBLTF) ("Lattice" or the "Company"), an emerging leader in psilocybin research and cannabis company, today